Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glavonoid for transthyretin amyloidosis
jRCTs071230091Recruiting
- Sponsor
- Nagasaki International University
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in transthyretin amyloidosis (ATTR) comparing Glavonoid arm with Placebo arm (2 arms). Primary endpoints: Physical examination, Nutrition and 11 more. Started Jan 2024; status: recruiting.
02
Drugs
glavonoid
03
Conditions
transthyretin amyloidosis (ATTR)
Beyond the preview
Go deeper on jRCTs071230091.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs071230091.